Managing Director, Biotech Mountains BV

25 years of leadership experience in the biotech industry

After five years at the pharmaceutical practice of McKinsey & Co., Alexander continued at Genzyme Therapeutics Europe, holding several executive positions, including global responsibility for the Genzyme/Pharming JV to develop an ERT for Pompe’s Disease

Served as CEO of MediService AG (Switzerland), one of the leading specialty pharmacy service companies in Europe, which was successfully sold to Galenica AG

Member of the management board, deputy-CEO and COO of PAION AG, a publicly listed, clinical stage biopharma company

CEO of PharmaCell BV; helped turn it into the leading European CMO for cell and gene therapy. PharmaCell was sold to Lonza in May 2017 creating a successful exit for investors